Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Method of transmitting and receiving wireless resource information
System and method for investing public deposits
Control method of LPI lamp for LPI vehicle and logic therefor
Maize variety hybrid X13A495
Bio-stimulant for improved plant growth and development
Recovery of a hot-pluggable serial communication link
Lubricant supplying device, process cartridge, and image forming apparatus
  Randomly Featured Patents
Multi-layer pipe
Production of metal lumps and apparatus therefor
Handle collar for a bat
Data processing apparatus and system
Encapsulant composition and electronic package utilizing same
Group II alloyed I-III-VI semiconductor nanocrystal compositions and methods of making same
Tilt back chair and control
Benzothiophene compounds, intermediates, compositions, and method of treating endomethiosis
Substituted 6,7-methylene pyrido[1,2-a]pyrimidines useful as anti-allergic and anti-ulcer agents
Process for removing asphaltenic particles